Robustness of Clonogenic Assays as a Biomarker for Cancer Cell Radiosensitivity

Robustness of Clonogenic Assays as a Biomarker for Cancer Cell Radiosensitivity

Photon radiation therapy is a major curative treatment for cancer. However, the lack of robust predictive biomarkers for radiosensitivity precludes personalized radiation therapy. Clonogenic assays are the gold standard method for measuring the radiosensitivity of cancer cells. Although a large numb...

Full description

Bibliographic Details
Main Authors: Toshiaki Matsui, Endang Nuryadi, Shuichiro Komatsu, Yuka Hirota, Atsushi Shibata, Takahiro Oike, Takashi Nakano
Format: Article
Language:English
Published: MDPI AG 2019-08-01
Series:International Journal of Molecular Sciences
Subjects:
cancer
precision medicine
radiation therapy
radiosensitivity
clonogenic assays
Online Access:https://www.mdpi.com/1422-0067/20/17/4148

Internet

https://www.mdpi.com/1422-0067/20/17/4148

Similar Items